LIVE EVENT: The U.S. healthcare law rollout: Where do we stand?
BASEL - Fifteen years ago Ian Parkhill was diagnosed with a rare muscle-wasting disease that gradually robbed him of the strength in his thighs.
- GlaxoSmithKline and Theravance Inc said on Friday that their combination therapy met the main goal of improving lung function in asthma patients in a late-stage trial.
ZURICH - An experimental drug from Novartis to treat a type of bone marrow cancer met its primary goal in a late-stage study, the Swiss drugmaker said on Friday.
NEW YORK (Reuters Health) - Exercise can help overweight kids slim down, but a new study suggests they might be at risk for leg, ankle and foot injuries in the process.
NEW YORK (Reuters Health) - It's never too late to start exercising, according to a new study that found formerly inactive seniors who took up exercise still experienced health benefits.
HONG KONG - Hong Kong has confirmed its second case of the deadly H7N9 bird flu, days after the first, as the virus spreads beyond mainland China, authorities said on Friday night.
- An experimental drug for ulcerative colitis and Crohn's disease from Takeda Pharmaceutical Co could pose risk of a potentially fatal brain infection called PML even though the problem has not been seen in clinical trials, staff members of the U.S. Food and Drug Administration said on Thursday.
COPENHAGEN - Danish healthcare products maker Coloplast aims for another year of double-digit organic growth in the United States, its chief financial officer told Reuters on Friday.
LONDON - European regulators have started an in-depth review of the benefits and risks of Ariad Pharmaceuticals Inc's leukaemia medicine Iclusig.
LONDON - Researchers cast doubt on the prevailing wisdom that vitamin D supplements can prevent conditions like cancer, diabetes and heart disease, saying on Friday low vitamin D may be a consequence, not a cause, of ill health.
On Wednesday, December 4 at 10:30 a.m. watch live as experts assess where the U.S. stands in the healthcare law rollout and the resulting health policy implications. Presented by the forum at Harvard School of Public Health in collaboration with Reuters. Live Coverage